Product image of Xevudy (Sotrovimab) supplied by GNH India

Xevudy

Active Ingredient:
Sotrovimab
Origin:
EU

Xevudy (Sotrovimab)

Xevudy (sotrovimab) is a monoclonal antibody treatment for COVID-19 in high-risk adults and adolescents. Designed to reduce hospitalization risk, it targets the SARS-CoV-2 virus. This overview covers key details for informed use. Xevudy sotrovimab COVID-19 treatment overview for safe use.

Manufacturer / TM Owner

Glaxosmithkline Trading Services Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Xevudy (sotrovimab) is used to treat mild-to-moderate COVID-19 in adults and adolescents who are at high risk of progressing to severe disease. It may help reduce the risk of hospitalization or severe outcomes when given early in infection. People often ask, what is Xevudy used for, and the answer is COVID-19 treatment for high-risk patients. It is not a substitute for vaccination but provides an option for those already infected.

Side Effects

  • Xevudy works by binding to the spike protein of the SARS-CoV-2 virus, helping the immune system recognize and neutralize the virus. Patients may experience relief from symptoms such as fever, cough, and fatigue as the treatment takes effect. Common effects include temporary improvement in breathing and energy levels during recovery. Most people tolerate it well without significant discomfort.

Precautions & Warnings

  • Xevudy should be administered under medical supervision by healthcare professionals in a clinical setting. Patients with known allergies to any component of the drug should avoid it. Pregnant or breastfeeding individuals should discuss risks with their doctor before use. Keep all follow-up appointments to monitor response and any potential reactions.

Avoid Interactions

  • Limited data exist on drug interactions with Xevudy, but caution is advised when combining with other monoclonal antibodies or immunomodulators. No specific interactions with common medications like pain relievers or antibiotics have been reported. Always inform your healthcare provider about all medications you are taking to assess potential risks. Avoid alcohol during treatment to support recovery.

Frequently Asked Questions

Xevudy is given as a single intravenous infusion by a healthcare professional in a clinical setting.

People with known allergies to sotrovimab or any ingredient in the formulation should avoid it.

No, Xevudy is not authorized for pre-exposure or post-exposure prevention of COVID-19.

Common side effects may include infusion-related reactions like fever, chills, or nausea.

No, Xevudy is a monoclonal antibody treatment for active COVID-19 infection, not a vaccine.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sotrovimab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT